Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
ASCO believes that high-quality observational studies can advance evidence-based practice for cancer care and are complementary to randomized controlled trials (RCTs). Observational studies can generate hypotheses by evaluating novel exposures or biomarkers and by revealing patterns of care and relationships that might not otherwise be discovered. Researchers can then test these hypotheses in RCTs. Observational studies can also answer or inform questions that either have not been or cannot be answered by RCTs. In addition, observational studies can be used for postmarketing surveillance of new cancer treatments, particularly in vulnerable populations. The incorporation of observational research as part of clinical decision making is consistent with the position of many leading institutions. ASCO identified five overarching recommendations to enhance the role of observational research in clinical decision making: (1) improve the quality of electronic health data available for research, (2) improve interoperability and the exchange of electronic health information, (3) ensure the use of rigorous observational research methodologies, (4) promote transparent reporting of observational research studies, and (5) protect patient privacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919
Krumholz, H. M. (2014) · Health Affairs · doi:10.1377/hlthaff.2014.0053 · Cited by 589
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population, Board on Health Care Services, & Institute of Medicine (2013) · doi:10.17226/18359 · Cited by 480
Benchimol, E. I., Manuel, D. G., To, T., Griffiths, A. M., Rabeneck, L., & Guttmann, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.006 · Cited by 368
Cox, E., Martin, B. C., Van Staa, T., Garbe, E., Siebert, U., & Johnson, M. L. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00601.x · Cited by 307
Johnson, M. L., Crown, W., Martin, B. C., Dormuth, C. R., & Siebert, U. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00602.x · Cited by 285
Nicholls, S. G., Quach, P., von Elm, E., Guttmann, A., Moher, D., Petersen, I., Sørensen, H. T., Smeeth, L., Langan, S. M., & Benchimol, E. I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125620 · Cited by 217
Cited by
Avoidable flaws in observational analyses: an application to statins and cancer
Dickerman, B. A., García-Albéniz, X., Logan, R. W., Denaxas, S., & Hernán, M. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0597-x · Cited by 308
Re‐inventing the randomized controlled trial in medical oncology: The registry‐based trial
Foroughi, S., Wong, H., Gately, L., Lee, M., Simons, K., Tie, J., Burgess, A. W., & Gibbs, P. (2018) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12992 · Cited by 43
Tan, R. S. Y. C., Lin, Q., Low, G. H., Lin, R., Goh, T. C., Chang, C. C. E., Lee, F. F., Chan, W. Y., Tan, W. C., Tey, H. J., et al. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad133 · Cited by 41
Toward responsible clinical n-of-1 strategies for rare diseases
Defelippe, V. M., J.M.W. van Thiel, G., Otte, W. M., Schutgens, R. E. G., Stunnenberg, B., Cross, H. J., O'Callaghan, F., De Giorgis, V., Jansen, F. E., Perucca, E., et al. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103688 · Cited by 30
“18,19 Optimized clinical practice or quality improvement can use aspects of research methodology, such as data collection or improved outcome monitoring, although the primary aim is to improve care for the individual patient.”
Metadata
- Authors
- Visvanathan, K., Levit, L. A., Raghavan, D., Hudis, C. A., Wong, S., Dueck, A., & Lyman, G. H.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-06-01
- Volume
- 35
- Issue
- 16
- Pages
- 1845-1854
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2602748113
- Cited by
- 112
- References
- 12
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement. https://app.cochat.ai/papers/10.1200/jco.2017.72.6414
- The paper
- Visvanathan, K., Levit, L. A., Raghavan, D., Hudis, C. A., Wong, S., Dueck, A., & Lyman, G. H. (2017). Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2017.72.6414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.